Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose

After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivolta, Federica, Camilla, Cappelletti, Sangalli, Andrea, Chiei Gallo, Alessandra, Pravettoni, Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552543/
https://www.ncbi.nlm.nih.gov/pubmed/36245445
http://dx.doi.org/10.1002/ccr3.6348
_version_ 1784806272066912256
author Rivolta, Federica
Camilla, Cappelletti
Sangalli, Andrea
Chiei Gallo, Alessandra
Pravettoni, Valerio
author_facet Rivolta, Federica
Camilla, Cappelletti
Sangalli, Andrea
Chiei Gallo, Alessandra
Pravettoni, Valerio
author_sort Rivolta, Federica
collection PubMed
description After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, without presenting immediate or delayed reactions.
format Online
Article
Text
id pubmed-9552543
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95525432022-10-14 Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose Rivolta, Federica Camilla, Cappelletti Sangalli, Andrea Chiei Gallo, Alessandra Pravettoni, Valerio Clin Case Rep Case Report After a suspected allergic reaction to first dose of mRNA COVID‐19 vaccine, given the PEG skin tests negativity and tolerance in vivo to PEG containing drugs, five patients were vaccinated with the second dose of Pfizer‐Biontech undergoing a fractional protocol, with antihistamine premedication, without presenting immediate or delayed reactions. John Wiley and Sons Inc. 2022-10-11 /pmc/articles/PMC9552543/ /pubmed/36245445 http://dx.doi.org/10.1002/ccr3.6348 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Rivolta, Federica
Camilla, Cappelletti
Sangalli, Andrea
Chiei Gallo, Alessandra
Pravettoni, Valerio
Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title_full Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title_fullStr Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title_full_unstemmed Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title_short Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
title_sort successful fractionated undiluted doses of covid‐19 vaccine in five cases of suspected allergic reactions to the first dose
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552543/
https://www.ncbi.nlm.nih.gov/pubmed/36245445
http://dx.doi.org/10.1002/ccr3.6348
work_keys_str_mv AT rivoltafederica successfulfractionatedundiluteddosesofcovid19vaccineinfivecasesofsuspectedallergicreactionstothefirstdose
AT camillacappelletti successfulfractionatedundiluteddosesofcovid19vaccineinfivecasesofsuspectedallergicreactionstothefirstdose
AT sangalliandrea successfulfractionatedundiluteddosesofcovid19vaccineinfivecasesofsuspectedallergicreactionstothefirstdose
AT chieigalloalessandra successfulfractionatedundiluteddosesofcovid19vaccineinfivecasesofsuspectedallergicreactionstothefirstdose
AT pravettonivalerio successfulfractionatedundiluteddosesofcovid19vaccineinfivecasesofsuspectedallergicreactionstothefirstdose

Ejemplares similares